Please Wait.....
Report
Gastroparesis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-11-24 I 149 Pages I IMARC Group
The global gastroparesis drugs market size reached US$ 6.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.2 Billion by 2028, exhibiting a growth rate (CAGR) of 4.77% during 2022-2028.
Gastroparesis, also known as stomach paralysis, is a medical condition that affects the normal and spontaneous movement of the muscles in the stomach. It interferes with the digestion process and causes nausea, vomiting, abdominal pain, and problems with maintaining blood sugar levels and nutrition absorption. At present, it is treated under the guidance of doctors using drugs, such as domperidone, metoclopramide, erythromycin, diphenhydramine, ondansetron, and prochlorperazine.
Gastroparesis Drugs Market Trends:
Due to rapid urbanization, sedentary lifestyles and the growing number of individuals who drink and smoke regularly, there is a significant rise in the prevalence of diabetes across the globe. This, in confluence with the increasing geriatric population, which is relatively more susceptible to developing gastroparesis, represents one of the key factors bolstering the growth of the market. In addition, gastroparesis drugs aid in enhancing gastrointestinal motility by improving the frequency of contraction. As a result, they are extensively being utilized for treating idiopathic gastroparesis, which causes severe vomiting, nausea, and upper abdominal pain. This, along with a considerable rise in the number of individuals developing gastroparesis after the vague nerve and its branches are damaged via surgical operations, are also contributing to market growth. Furthermore, leading manufacturers are continuously funding research and development (R&D) projects to introduce new approaches to the existing drug therapy. They are also developing advanced and effective drugs that can be administered via the nasal cavity for individuals who are experiencing symptoms of gastroparesis, which is creating a favorable market outlook. Other major factors, including the improving healthcare infrastructure and the escalating demand for user-friendly drugs, are anticipated to impel the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gastroparesis drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease type, drug class and distribution channel.
Breakup by Disease Type:
Diabetic Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
Others
Breakup by Drug Class:
Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injections
Breakup by Distribution Channel:
Hospitals and Clinics
Pharmacies
Online Stores
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Abbvie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Becton Dickinson and Company, Boston Scientific Corporation, Evoke Pharma, Medtronic plc, Neurogastrx Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Theravance Biopharma.
Key Questions Answered in This Report
1. What was the size of the global gastroparesis drugs market in 2022?
2. What is the expected growth rate of the global gastroparesis drugs market during 2023-2028?
3. What has been the impact of COVID-19 on the global gastroparesis drugs market?
4. What are the key factors driving the global gastroparesis drugs market?
5. What is the breakup of the global gastroparesis drugs market based on the disease type?
6. What is the breakup of the global gastroparesis drugs market based on the drug class?
7. What is the breakup of the global gastroparesis drugs market based on the distribution channel?
8. What are the key regions in the global gastroparesis drugs market?
9. Who are the key players/companies in the global gastroparesis drugs market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Gastroparesis Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease Type
6.1 Diabetic Gastroparesis
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Idiopathic Gastroparesis
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Post-surgical Gastroparesis
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Prokinetic Agents
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Antiemetic Agents
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Botulinum Toxin Injections
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Abbvie Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 AstraZeneca Plc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bausch Health Companies Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Becton Dickinson and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Boston Scientific Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Evoke Pharma
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Medtronic plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Neurogastrx Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Sanofi S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Takeda Pharmaceutical Company Limited
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Theravance Biopharma
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
Figure 1: Global: Gastroparesis Drugs Market: Major Drivers and Challenges
Figure 2: Global: Gastroparesis Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Gastroparesis Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Gastroparesis Drugs Market: Breakup by Disease Type (in %), 2022
Figure 5: Global: Gastroparesis Drugs Market: Breakup by Drug Class (in %), 2022
Figure 6: Global: Gastroparesis Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Gastroparesis Drugs Market: Breakup by Region (in %), 2022
Figure 8: Global: Gastroparesis Drugs (Diabetic Gastroparesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Gastroparesis Drugs (Diabetic Gastroparesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Gastroparesis Drugs (Idiopathic Gastroparesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Gastroparesis Drugs (Idiopathic Gastroparesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Gastroparesis Drugs (Post-surgical Gastroparesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Gastroparesis Drugs (Post-surgical Gastroparesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Gastroparesis Drugs (Other Disease Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Gastroparesis Drugs (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Gastroparesis Drugs (Prokinetic Agents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Gastroparesis Drugs (Prokinetic Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Gastroparesis Drugs (Antiemetic Agents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Gastroparesis Drugs (Antiemetic Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Gastroparesis Drugs (Botulinum Toxin Injections) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Gastroparesis Drugs (Botulinum Toxin Injections) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Gastroparesis Drugs (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Gastroparesis Drugs (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Gastroparesis Drugs (Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Gastroparesis Drugs (Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Gastroparesis Drugs (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Gastroparesis Drugs (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Gastroparesis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Gastroparesis Drugs Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Gastroparesis Drugs Industry: SWOT Analysis
Figure 78: Global: Gastroparesis Drugs Industry: Value Chain Analysis
Figure 79: Global: Gastroparesis Drugs Industry: Porter's Five Forces Analysis
Table 1: Global: Gastroparesis Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Gastroparesis Drugs Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
Table 3: Global: Gastroparesis Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 4: Global: Gastroparesis Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Gastroparesis Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Gastroparesis Drugs Market: Competitive Structure
Table 7: Global: Gastroparesis Drugs Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security